Biotin ergopeptide probes for dopamine receptors

Journal of Medicinal Chemistry

Volumn 54, Issue 4, 2011, Pages 1080-1090

  Vendrell, Marc ^a,c   Molero, Anabel ^a   González, Sergio ^a   Pérez Capote, Kamil ^a   Lluis, Carme ^a   McCormick, Peter J ^a   Franco, Rafael ^a   Cortés, Antoni ^a   Casadó, Vicent ^a   Albericio, Fernando ^a,b   Royo, Miriam ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN ERGOPEPTIDE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; RADIOLIGAND; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DERIVATIZATION; NONHUMAN;

ANIMALS; BINDING, COMPETITIVE; BIOTIN; CHO CELLS; CRICETINAE; CRICETULUS; ERGOTAMINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE LIBRARY; PEPTIDES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 79951833480     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101566d     Document Type: Article

References (36)

1. Vendrell, M.; Angulo, E.; Casadó, V.; Lluis, C.; Franco, R.; Albericio, F.; Royo, M. Novel ergopeptides as dual ligands for (Pubitemid 47001249)
2. Maggio, R.; Aloisi, G.; Silvano, E.; Rossi, M.; Millan, M. J. Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance Parkinsonism Relat. Disord. 2009, 15 (S4) S2-S7
3. So, C. H.; Verma, V.; O'Dowd, B. F.; George, S. R. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor Mol. Pharmacol. 2007, 72, 450-462 (Pubitemid 47124125)
4. 2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor Mol. Pharmacol. 2005, 68, 568-578 (Pubitemid 41206010)
5. Bhushan, R. G.; Sharma, S. K.; Xie, Z.; Daniels, D. J.; Portoghese, P. S. A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers J. Med. Chem. 2004, 47, 2969-2972 (Pubitemid 38702692)
6. Waldhoer, M.; Fong, J.; Jones, R. M.; Lunzer, M. M.; Sharma, S. K.; Kostenis, E.; Portoghese, P. S.; Whistler, J. L. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 9050-9055 (Pubitemid 40881076)
7. Adam, G. C.; Sorensen, E. J.; Cravatt, B. F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype Nature Biotechnol. 2002, 20, 805-809 (Pubitemid 34836757)
8. Speers, A. E.; Adam, G. C.; Cravatt, B. F. Activity-based protein profiling in vivo using a copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition J. Am. Chem. Soc. 2003, 125, 4686-4687 (Pubitemid 36505343)
9. Walsh, D. P.; Chang, Y. T. Chemical genetics Chem. Rev. 2006, 106, 2476-2530
10. 1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells J. Med. Chem. 2007, 50, 782-793 (Pubitemid 46335649)
11. Lokey, R. S. Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia Curr. Opin. Chem. Biol. 2003, 7, 91-96 (Pubitemid 36126498)
12. Middleton, R. J.; Kellam, B. Fluorophore-tagged GPCR ligands Curr. Opin. Chem. Biol. 2005, 9, 517-525 (Pubitemid 41338206)
13. Gellerman, G.; Elgavi, A.; Salitra, A.; Kramer, M. Novel Gly building units for backbone cyclization: synthesis and incorporation into model peptides J. Pept. Res. 2001, 57, 277-291
14. Vendrell, M.; Ventura, R.; Ewenson, A.; Royo, M.; Albericio, F. N -[Chloro(dimethylamino)methylene]- N -methylmethanaminium chloride (TMUCl Cl), the reagent of choice for the solid-phase synthesis of anilides Tetrahedron Lett. 2005, 46, 5383-5386 (Pubitemid 40957047)
15. Baraldi, P. G.; Tabrizi, M. A.; Gessi, S.; Borea, P. A. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility Chem. Rev. 2008, 108, 238-263 (Pubitemid 351176408)
16. Agnati, L. F.; Ferré, S.; Lluis, C.; Franco, R.; Fuxe, K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons Pharmacol. Rev. 2003, 55, 509-550 (Pubitemid 37013214)
17. Franco, R.; Casadó, V.; Mallol, J.; Ferré, S.; Fuxe, K.; Cortés, A.; Ciruela, F.; Lluis, C.; Canela, E. I. Dimer-based model for heptaspanning membrane receptors Trends Biochem. Sci. 2005, 300, 360-366 (Pubitemid 40942030)
18. Bayer, E. A.; Wilchek, M. Application of avidin-biotin technology to affinity-based separations J. Chromatogr. 1990, 510, 3-11 (Pubitemid 20197875)
19. Elia, G. Biotinylation reagents for the study of cell surface proteins Proteomics 2008, 8, 4012-4024
20. Bratthauer, G. L. The avidin-biotin complex (ABC) and other avidin-biotin binding methods Methods Mol. Biol. 1999, 115, 203-214
21. Smith, D. J.; Shappell, N. W. Technical note: epimerization of ergopeptine alkaloids in organic and aqueous solvents J. Anim. Sci. 2002, 80, 1616-1622 (Pubitemid 41151724)
22. Chausmer, A. L.; Katz, J. L. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958, and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents Psychopharmacology 2002, 159, 145-153 (Pubitemid 34146557)
23. 2-like dopamine receptors in rat brain J. Pharmacol. Exp. Ther. 1992, 262, 929-935
24. Beaulieu, J.; Gainetdinov, R. R.; Caron, M. G. The Akt/GSK-3 signaling cascade in the actions of dopamine Trends Pharmacol. Sci. 2007, 28, 166-172 (Pubitemid 46483722)
25. Beaulieu, J.; Gainetdinov, R. R.; Caron, M. G. Akt/GSK3 signaling in the action of psychotropic drugs Annu. Rev. Pharmacol. Toxicol. 2009, 49, 327-347
26. 3 receptor interactions in the striatum J. Biol. Chem. 2008, 283, 26016-26025
27. 3 receptors Br. J. Pharmacol. 2009, 157, 64-75
28. 2 receptors and the implications for striatal function Neuropharmacology 2008, 55, 190-197
29. 2A receptors form higher-order oligomers in living cells J. Neurochem. 2009, 109, 1497-1507
30. 2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 2005, 67, 1697-1704 (Pubitemid 40594170)
31. Rocheville, M.; Lange, D. C.; Kumar, U.; Patel, S. C.; Patel, R. C.; Patel, Y. C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity Science 2000, 288, 154-157 (Pubitemid 30203051)
32. Vazquez, J.; Qushair, G.; Albericio, F. Qualitative colorimetric tests for solid phase synthesis Methods Enzymol. 2003, 369, 21-35 (Pubitemid 38002098)
33. Strohmeier, G. A.; Haas, W.; Kappe, C. O. Synthesis of functionalized 1,3-thiazine libraries combining solid-phase synthesis and post-cleavage modification methods Chem.-Eur. J. 2004, 10, 2919-2926
34. Attardi, M. E.; Porcu, G.; Taddei, M. Malachite green, a valuable reagent to monitor the presence of free COOH on the solid-phase Tetrahedron. Lett. 2000, 41, 7391-7394
35. Casadó, V.; Ferrada, C.; Bonaventura, J.; Gracia, E.; Mallol, J.; Canela, E. I.; Lluís, C.; Cortés, A.; Franco, R. Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation Biochem. Pharmacol. 2009, 78, 1456-1463
36. Casadó, V.; Cortés, A.; Ciruela, F.; Mallol, J.; Ferré, S.; Lluís, C.; Canela, E. I.; Franco, R. Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index Pharmacol. Ther. 2007, 116, 343-354 (Pubitemid 350123634)